This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Identification and Utilization of Donor and Recipient Genetic Variants to Predict Survival After HCT: Are We Ready for Primetime?
Current Hematologic Malignancy Reports Open Access 21 February 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sairafi D, Uzunel M, Remberger M, Ringden O, Mattsson J . No impact of NOD2/CARD15 on outcome after SCT. Bone Marrow Transplant 2008; 41: 961–964.
Mayor NP, Shaw BE, Hughes DA, Maldonado-Torres H, Madrigal JA, Keshav S et al. Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. J Clin Oncol 2007; 25: 4262–4269.
Holler E, Rogler G, Brenmoehl J, Hahn J, Herfarth H, Greinix H et al. Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination. Blood 2006; 107: 4189–4193.
Holler E, Rogler G, Herfarth H, Brenmoehl J, Wild PJ, Hahn J et al. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 2004; 104: 889–894.
Granell M, Urbano-Ispizua A, Arostegui JI, Fernandez-Aviles F, Martinez C, Rovira M et al. Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation. Haematologica 2006; 91: 1372–1376.
Elmaagacli AH, Koldehoff M, Hindahl H, Steckel NK, Trenschel R, Peceny R et al. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. Transplantation 2006; 81: 247–254.
Holler E, Hahn J, Andreesen R, Rogler G, Brenmoehl J, Greinix H et al. NOD2/CARD15 polymorphisms in allogeneic stem-cell transplantation from unrelated donors: T depletion matters. J Clin Oncol 2008; 26: 338–339.
Mayor NP, Shaw BE, Hughes DA, Maldonado-Torres H, Madrigal JA, Keshav S et al. In Reply. J Clin Oncol 2008; 26: 339.
Hugot JP, Zaccaria I, Cavanaugh J, Yang H, Vermeire S, Lappalainen M et al. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol 2007; 102: 1259–1267.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mayor, N., Shaw, B., Madrigal, J. et al. No impact of NOD2/CARD15 on outcome after SCT: a reply. Bone Marrow Transplant 42, 837–838 (2008). https://doi.org/10.1038/bmt.2008.251
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.251
This article is cited by
-
Identification and Utilization of Donor and Recipient Genetic Variants to Predict Survival After HCT: Are We Ready for Primetime?
Current Hematologic Malignancy Reports (2015)